For T1b or T2a NSCLC cancer, approached with SABR, should chemotherapy be considered in the adjuvant setting?   

As it is suggested for larger tumors treated with surgery, based on post hoc CALGB analysis?



Answer from: Medical Oncologist at Academic Institution

Answer from: Radiation Oncologist at Community Practice